TD Asset Management
CLVS

TD Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

TD Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,685
Closed -$863K – 1378
2017
Q4 		$863K Sell
12,685
-11,800
-48% -$825K ﹤0.01% 1084
2017
Q3 		$2.02M Sell
24,485
-18,367
-43% -$1.46M ﹤0.01% 862
2017
Q2 		$4.01M Buy
42,852
+33,326
+350% +$2.04M 0.01% 721
2017
Q1 		$607K Sell
9,526
-7,700
-45% -$468K ﹤0.01% 1168
2016
Q4 		$765K Sell
17,226
-13,474
-44% -$474K ﹤0.01% 1078
2016
Q3 		$1.11M Sell
30,700
-5,400
-15% -$116K ﹤0.01% 986
2016
Q2 		$495K Sell
36,100
-500
-1% -$7.31K ﹤0.01% 1122
2016
Q1 		$703K Sell
36,600
-1,200
-3% -$25.4K ﹤0.01% 1037
2015
Q4 		$1.32M Sell
37,800
-9,000
-19% -$580K ﹤0.01% 898
2015
Q3 		$4.3M Sell
46,800
-1,000
-2% -$86.5K 0.01% 675
2015
Q2 		$4.2M Sell
47,800
-6,200
-11% -$531K 0.01% 728
2015
Q1 		$4.01M Buy
54,000
+4,200
+8% +$297K 0.01% 710
2014
Q4 		$2.79M Buy
49,800
+25,100
+102% +$1.32M ﹤0.01% 793
2014
Q3 		$1.12M Sell
24,700
-1,000
-4% -$41.8K ﹤0.01% 890
2014
Q2 		$1.06M Buy
25,700
+8,100
+46% +$417K ﹤0.01% 898
2014
Q1 		$1.22M Buy
17,600
+900
+5% +$66.1K ﹤0.01% 880
2013
Q4 		$1.01M Buy
16,700
+6,500
+64% +$354K ﹤0.01% 885
2013
Q3 		$620K Hold
10,200
– – ﹤0.01% 935
2013
Q2 		$683K Buy
+10,200
New +$459K ﹤0.01% 888

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

TD Asset Management's CLVS Position: Q1 2018 in Review

TD Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q1 2018, closing a stake of 12,685 shares — an estimated $863K sold.

TD Asset Management first reported a position in CLVS in Q2 2013 and held it in 19 quarters. The position peaked at $4.3M in Q3 2015. 229 funds tracked by Wall St. Rank hold CLVS as of Q1 2018.

  • TD Asset Management reported no remaining Clovis Oncology, Inc. position as of Q1 2018 after selling out during the quarter.
  • TD Asset Management sold 12,685 Clovis Oncology, Inc. shares in Q1 2018, an estimated $863K.
  • TD Asset Management first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 19 quarters.
  • TD Asset Management's Clovis Oncology, Inc. position peaked at $4.3M in Q3 2015.
  • 229 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2018.

Based on TD Asset Management's 13F filing for Q1 2018, filed 11 May 2018.